Lu Jun-Lan, Zeng Xue-Shan, Zhou Xin, Yang Jun-Ling, Ren Ling-Ling, Long Xin-Yu, Wang Feng-Qing, Olaleye Olajide E, Tian Nan-Nan, Zhu Ya-Xuan, Dong Jia-Jia, Jia Wei-Wei, Li Chuan
Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Front Pharmacol. 2022 May 10;13:911982. doi: 10.3389/fphar.2022.911982. eCollection 2022.
Phenolic acids are cardiovascular constituents (originating from the Chinese medicinal herb root/Danshen) of DanHong and many other Danshen-containing injections. Our earlier pharmacokinetic investigation of DanHong suggested that hepatic and/or renal uptake of the Danshen compounds was the crucial steps in their systemic elimination. This investigation was designed to survey the molecular basis underlying hepatobiliary and renal excretion of the Danshen compounds, i.e., protocatechuic acid, tanshinol, rosmarinic acid, salvianolic acid D, salvianolic acid A, lithospermic acid, and salvianolic acid B. A large battery of human hepatic and renal transporters were screened for transporting the Danshen compounds and then characterized for the uptake kinetics and also compared with associated rat transporters. The samples were analyzed by liquid chromatography/mass spectrometry. Because the Danshen phenolic acids are of poor or fairly good membrane permeability, their elimination the liver or kidneys necessitates transporter-mediated hepatic or renal uptake from blood. Several human transporters were found to mediate hepatic and/or renal uptake of the Danshen compounds in a compound-molecular-mass-related manner. Lithospermic acid and salvianolic acid B (both >500 Da) underwent systemic elimination, initiated by organic anion-transporting polypeptide (OATP)1B1/OATP1B3-mediated hepatic uptake. Rosmarinic acid and salvianolic acids D (350-450 Da) underwent systemic elimination, initiated by OATP1B1/OATP1B3/organic anion transporter (OAT)2-mediated hepatic uptake and by OAT1/OAT2-mediated renal uptake. Protocatechuic acid and tanshinol (both <200 Da) underwent systemic elimination, initiated by OAT1/OAT2-mediated renal uptake and OAT2-mediated hepatic uptake. A similar scenario was observed with the rat orthologs. The investigation findings advance our understanding of the disposition of the Danshen phenolic acids and could facilitate pharmacokinetic research on other Danshen-containing injections.
酚酸是丹红及许多其他含丹参注射液的心血管活性成分(源自中药丹参根)。我们早期对丹红的药代动力学研究表明,丹参化合物的肝脏和/或肾脏摄取是其全身消除的关键步骤。本研究旨在探究丹参化合物(即原儿茶酸、丹参素、迷迭香酸、丹酚酸D、丹酚酸A、紫草酸、丹酚酸B)肝胆和肾脏排泄的分子基础。对一系列人类肝脏和肾脏转运体进行筛选,以确定其对丹参化合物的转运作用,然后对摄取动力学进行表征,并与相关大鼠转运体进行比较。样品通过液相色谱/质谱法进行分析。由于丹参酚酸的膜通透性较差或中等,它们在肝脏或肾脏中的消除需要转运体介导的从血液中的肝脏或肾脏摄取。发现几种人类转运体以与化合物分子量相关的方式介导丹参化合物的肝脏和/或肾脏摄取。紫草酸和丹酚酸B(均>500 Da)的全身消除由有机阴离子转运多肽(OATP)1B1/OATP1B3介导的肝脏摄取启动。迷迭香酸和丹酚酸D(350 - 450 Da)的全身消除由OATP1B1/OATP1B3/有机阴离子转运体(OAT)2介导的肝脏摄取和OAT1/OAT2介导的肾脏摄取启动。原儿茶酸和丹参素(均<200 Da)的全身消除由OAT1/OAT2介导的肾脏摄取和OAT2介导的肝脏摄取启动。在大鼠同源物中也观察到类似情况。该研究结果增进了我们对丹参酚酸处置的理解,并有助于对其他含丹参注射液进行药代动力学研究。